All-cause and cardiovascular mortality after hysterectomy and oophorectomy in a large cohort (HUNT2).


Journal

Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343

Informations de publication

Date de publication:
04 2023
Historique:
revised: 02 01 2023
received: 18 09 2022
accepted: 21 01 2023
pubmed: 24 2 2023
medline: 15 3 2023
entrez: 23 2 2023
Statut: ppublish

Résumé

Hysterectomy and bilateral oophorectomy are common major surgical procedures that have been associated with increased mortality risk. We aimed to assess the association of hysterectomy and/or bilateral oophorectomy with all-cause and cardiovascular mortality in a Norwegian population. Cohort study with data from The Trøndelag Health Study (HUNT2) linked to the Norwegian Cause of Death Registry, with follow-up from 1996 until 2014 or death. The unexposed group (n = 18 673) included women with both their ovaries and uterus intact, while the two exposed groups included women with hysterectomy alone (n = 1199), or bilateral oophorectomy with or without hysterectomy (n = 907). We compared mortality in exposed vs unexposed groups and adjusted for relevant covariates by Cox regression. Further, we performed analyses stratified by age at surgery (≤39, 40-52, ≥53 years) and subgroup analyses among women ≤52 years of age at inclusion. Among the 47 312 women in HUNT2 (1995-1997), 20 779 provided complete information regarding gynecological surgery and previous health. The hysterectomy group had increased all-cause mortality (hazard ratio [HR] 1.30, 95% confidence interval [CI] 1.06-1.58) and cardiovascular mortality (HR 1.47, 95% CI 1.09-1.97). We found no significant association between bilateral oophorectomy and all-cause or cardiovascular mortality in the total population. However, among women ≤52 years at inclusion, cardiovascular mortality was increased in the hysterectomy group (HR 2.71, 95% CI 1.19-6.17) with a similar, but less precise estimate in the bilateral oophorectomy group (HR 2.42, 95% CI 0.84-6.93). Hysterectomy was associated with increased all-cause and cardiovascular mortality, whereas bilateral salpingo-oophorectomy was not. Among women ≤52 years at inclusion, both hysterectomy and bilateral oophorectomy were associated with a twofold increased risk of cardiovascular mortality, but the results were imprecise. Women after hysterectomy and/or bilateral salpingo-oophorectomy constitute a group with increased cardiovascular mortality that may need closer attention to cardiovascular disease risk from the healthcare system to ensure timely and effective preventive interventions.

Identifiants

pubmed: 36814418
doi: 10.1111/aogs.14531
pmc: PMC10008279
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

465-472

Subventions

Organisme : Southern and Eastern Norway Regional Health Authority
ID : 2021009
Organisme : Norwegian Research Center for Women's Health
Organisme : Sørlandet Hospital

Informations de copyright

© 2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).

Références

Menopause. 2021 Nov 01;29(1):28-34
pubmed: 34726195
J Am Coll Cardiol. 2013 Jul 16;62(3):191-200
pubmed: 23684687
Lancet Oncol. 2006 Oct;7(10):821-8
pubmed: 17012044
Menopause. 2009 Jan-Feb;16(1):15-23
pubmed: 19034050
Circulation. 2005 Mar 29;111(12):1462-70
pubmed: 15781742
Maturitas. 2006 Jan 20;53(2):226-33
pubmed: 15955642
Menopause. 2007 May-Jun;14(3 Pt 2):562-6
pubmed: 17476145
Arch Gynecol Obstet. 2022 May;305(5):1255-1263
pubmed: 34524503
Am J Obstet Gynecol. 2020 Nov;223(5):723.e1-723.e16
pubmed: 32376318
Menopause. 2018 May;25(5):483-492
pubmed: 29286988
BMJ. 2021 Dec 8;375:e067528
pubmed: 34880044
BJOG. 2005 Jul;112(7):956-62
pubmed: 15957999
Eur Heart J. 2011 Mar;32(6):745-50
pubmed: 21186237
JAMA Cardiol. 2016 Oct 1;1(7):767-776
pubmed: 27627190
J Clin Epidemiol. 2000 Aug;53(8):832-7
pubmed: 10942866
Biol Sex Differ. 2017 Oct 24;8(1):33
pubmed: 29065927
Acta Obstet Gynecol Scand. 2023 Apr;102(4):465-472
pubmed: 36814418
Hum Reprod. 2020 Feb 29;35(2):464-471
pubmed: 31990353
Menopause. 2017 Nov;24(11):1269-1276
pubmed: 28697037
Cochrane Database Syst Rev. 2015 Mar 10;(3):CD002229
pubmed: 25754617
J Clin Epidemiol. 2000 May;53(5):525-30
pubmed: 10812326
JAMA. 2019 Dec 24;322(24):2411-2421
pubmed: 31738818
Gynecol Oncol. 2008 Jun;109(3):377-83
pubmed: 18407340
Am J Epidemiol. 2015 Dec 15;182(12):991-9
pubmed: 26628512
Obstet Gynecol. 2013 Apr;121(4):709-716
pubmed: 23635669
Menopause. 2014 Jun;21(6):592-601
pubmed: 24253486
Eur J Prev Cardiol. 2016 Jan;23(2):178-86
pubmed: 25331207
Am J Obstet Gynecol. 2019 Jan;220(1):83.e1-83.e11
pubmed: 30312584

Auteurs

Trond M Michelsen (TM)

Division of Obstetrics and Gynecology, Department of Obstetrics, Oslo University Hospital, Oslo, Norway.
Norwegian Research Center for Women's Health, Oslo University Hospital, Oslo, Norway.
Research Unit, Sørlandet Hospital HF, Kristiansand, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Tina Ellinor Rosland (TE)

Research Unit, Sørlandet Hospital HF, Kristiansand, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Obstetrics and Gynecology, Sørlandet Hospital Arendal, Arendal, Norway.

Bjørn O Åsvold (BO)

K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Endocrinology, Clinic of Medicine, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.

Are H Pripp (AH)

Oslo Center of Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.
Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.

Astrid H Liavaag (AH)

Department of Obstetrics and Gynecology, Sørlandet Hospital Arendal, Arendal, Norway.

Nora Johansen (N)

Research Unit, Sørlandet Hospital HF, Kristiansand, Norway.
Department of Obstetrics and Gynecology, Sørlandet Hospital Arendal, Arendal, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH